P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA
Main Authors: | S. Huhn, A. M. Poos, E. K. Mai, M. Hänel, H. J. Salwender, J. Dürig, I. W. Blau, C. Scheid, K. C. Weisel, M. Munder, O. Berlanga, U. Bertsch, H. Goldschmidt, N. Weinhold |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000846392.99356.df |
Similar Items
-
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
by: Elias K. Mai, et al.
Published: (2023-01-01) -
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial
by: Hans Salwender, et al.
Published: (2024-12-01) -
P879: Withdrawn
Published: (2024-01-01) -
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer
by: Uribe Jesus, et al.
Published: (2005-09-01) -
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma
by: Mohamed H. S. Awwad, et al.
Published: (2018-10-01)